Home » Topics » BioWorld Science

BioWorld Science
RSS

Roche identifies new gamma-secretase inhibitors

April 17, 2018

ImmuPharma reports topline results of pivotal Lupuzor trial in lupus

April 17, 2018

Advent enters exclusive negotiations to acquire Sanofi's European generics business

April 17, 2018

G1 Therapeutics initiates phase Ib/II study of G1T38 with Tagrisso in NSCLC

April 17, 2018

Basilea licenses derazantinib from ArQule

April 17, 2018

Asana BioSciences divulges new P2X3 and/or P2X2/3 receptor antagonists

April 17, 2018

Mutabilis patents novel beta-lactamase inhibitors

April 17, 2018

NeurOp initiates phase I trial of NP-10679

April 17, 2018

LTP Technology allows enhanced liver targeting of tenofovir prodrugs

April 17, 2018

FDA clears IND for first-in-human trial of CAB-ROR2-ADC

April 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...